BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/14/2026 8:39:30 AM | Browse: 0 | Download: 0
Publication Name World Journal of Transplantation
Manuscript ID 114367
Country India
Received
2025-09-17 06:51
Peer-Review Started
2025-09-17 06:51
First Decision by Editorial Office Director
2025-09-25 08:18
Return for Revision
2025-09-25 08:18
Revised
2025-09-27 20:18
Publication Fee Transferred
Second Decision by Editor
2025-11-25 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-11-26 07:52
Articles in Press
2025-11-26 07:52
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-01-07 07:33
Publish the Manuscript Online
2026-01-14 08:39
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Expert Consensus
Article Title Induction therapy in kidney transplant recipients: A consensus statement of Indian Society of Organ Transplantation
Manuscript Source Invited Manuscript
All Author List Vivek B Kute, Manish Ramesh Balwani, Jigar B Shrimali, Amit Pasari, Vijay Kher, Mohan Punabhai Patel, Deodatta Chafekar, Swarnalata Guditi, Pratik Das, Gireesh Mathihally Siddaiah, Suraj Mohan Godara, Vinantt Bhargava, Anurag Gupta, Vishal Ramteke, Nishant Deshpande, Priyanka Tolani, Narayan Prasad, Radhika Krishna Patil, Ravi Mohanka, Sandeep Mahajan, Sourabh Sharma, Subho Banerjee, Divyesh P Engineer, Dhananjai Agarwal, Pranjal Kashiv, Arpita Lahiri, Narayan Prasad, Dinesh Khullar and Aneesh Srivastava
ORCID
Author(s) ORCID Number
Vivek B Kute http://orcid.org/0000-0002-0002-2854
Manish Ramesh Balwani http://orcid.org/0000-0003-3923-6953
Amit Pasari http://orcid.org/0000-0002-2182-0898
Deodatta Chafekar http://orcid.org/0009-0001-6922-362X
Pratik Das http://orcid.org/0000-0001-6484-4753
Vinantt Bhargava http://orcid.org/0000-0002-3360-4666
Vishal Ramteke http://orcid.org/0000-0001-6039-728X
Nishant Deshpande http://orcid.org/0009-0001-7947-8124
Narayan Prasad http://orcid.org/0000-0001-9801-0474
Sourabh Sharma http://orcid.org/0000-0003-2513-5131
Subho Banerjee http://orcid.org/0000-0001-8231-9987
Divyesh P Engineer http://orcid.org/0000-0002-7719-1461
Pranjal Kashiv http://orcid.org/0000-0002-4551-2574
Arpita Lahiri http://orcid.org/0000-0003-1569-356X
Funding Agency and Grant Number
Corresponding Author Manish Ramesh Balwani, DM, MD, Professor, Department of Nephrology, Saraswati Kidney Care Center, 13, Jaitala Road, Near Jaiprakash Nagar Metro Station, New Sneh Nagar, Nagpur 440015, Maharashtra, India. balwani.manish@yahoo.com
Key Words Kidney transplant; Induction therapy; Rabbit antithymocyte globulin; IL-2 receptor blockers; Rituximab; Consensus; Indian Society of Organ Transplantation
Core Tip Kidney transplantation is the most common solid organ transplantation in India, yet induction immunosuppression practices vary widely across centers. The Indian Society of Organ Transplantation (ISOT) conducted a nationwide survey and identified significant heterogeneity in induction therapy choice, dose, and duration. Through a structured Delphi consensus, ISOT developed 16 statements to guide practice. Rabbit antithymocyte globulin (rATG) remains the preferred induction for high immunological risk and deceased donor recipients, while interleukin-2 receptor anatagonists or low-dose rATG is suitable for low-risk cases. Rituximab is recommended for ABO-incompatible transplants. These India-specific guidelines provide a standardized framework to optimize patient outcomes and rationalize induction therapy.
Publish Date 2026-01-14 08:39
Citation

Kute VB, Balwani MR, Shrimali JB, Pasari A, Kher V, Patel MP, Chafekar D, Guditi S, Das P, Siddaiah GM, Godara SM, Bhargava V, Gupta A, Ramteke V, Deshpande N, Tolani P, Prasad N, Patil RK, Mohanka R, Mahajan S, Sharma S, Banerjee S, Engineer DP, Agarwal D, Kashiv P, Lahiri A, Prasad N, Khullar D, Srivastava A. Induction therapy in kidney transplant recipients: A consensus statement of Indian Society of Organ Transplantation. World J Transplant 2026; 16(1): 114367

URL https://www.wjgnet.com/2220-3230/full/v16/i1/114367.htm
DOI https://dx.doi.org/10.5500/wjt.v16.i1.114367
Full Article (PDF) WJT-16-114367-with-cover.pdf
Manuscript File 114367_Auto_Edited_064146.docx
Answering Reviewers 114367-answering-reviewers.pdf
Audio Core Tip 114367-audio.mpeg
Conflict-of-Interest Disclosure Form 114367-conflict-of-interest-statement.pdf
Copyright License Agreement 114367-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 114367-non-native-speakers.pdf
Peer-review Report 114367-peer-reviews.pdf
Scientific Misconduct Check 114367-scientific-misconduct-check.png
Scientific Editor Work List 114367-scientific-editor-work-list.pdf
CrossCheck Report 114367-crosscheck-report.pdf